GABAPENTIN
- Product NDC
- 61919-417
- 11-digit product format
- 619190417
- Labeler code
- 61919
- Product ID
- 61919-417_8643994f-4e6e-4572-e053-2991aa0a5b78
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA090705
- Marketing category
- ANDA
- Marketing start
- 2017-12-05
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-417-60 | GABAPENTIN | 60 in 1 BOTTLE | CAPSULE | 60 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-417 | GABAPENTIN TABLET GABAPENTIN CAPSULE [DIRECT RX] | 3 | Legacy NDC, 1 package rows | 20190412_2e319a08-901d-40a9-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-417-60 | 61919041760 | 60 CAPSULE in 1 BOTTLE (61919-417-60) | 60 capsule | 2019-04-09 | 0000-00-00 | No | No | Current |